Blueprint Medicines (Acquisition)
Funding Details
Awarder
RSS - www.prnewswire.com
Date Award
June 2, 2025
Vertical
Pharmaceuticals
Funding URL
View Funding Page
Company Info
Traction
Blueprint Medicines has a strong pipeline of drug candidates and has made significant progress in clinical trials.
Market
Immunology
Location
USA
Company Description

Blueprint Medicines is focused on developing targeted therapies for patients with genomically defined cancers, rare diseases, and cancer immunotherapy.

Links
Website
Back to HomeBack to Pharmaceuticals DealsView Funding Announcement